Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report

Infection with tuberculosis (TB) still considered a leading infectious cause of death, osteomyelitis TB rare entity, and being extraspinal MDR-TB make it very rare case; most of experience in treating osteomyelitis TB was derived from pulmonary TB experience, and we present a case of humerus MDR-TB...

Descripción completa

Detalles Bibliográficos
Autores principales: Naser, Naser, Abdulla, Habib, Kadhem, Husain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262133/
https://www.ncbi.nlm.nih.gov/pubmed/37333427
http://dx.doi.org/10.1186/s43162-023-00225-0
_version_ 1785058008431067136
author Naser, Naser
Abdulla, Habib
Kadhem, Husain
author_facet Naser, Naser
Abdulla, Habib
Kadhem, Husain
author_sort Naser, Naser
collection PubMed
description Infection with tuberculosis (TB) still considered a leading infectious cause of death, osteomyelitis TB rare entity, and being extraspinal MDR-TB make it very rare case; most of experience in treating osteomyelitis TB was derived from pulmonary TB experience, and we present a case of humerus MDR-TB that was treated for 5 years, with several interruption due to side effect and other causes.
format Online
Article
Text
id pubmed-10262133
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-102621332023-06-14 Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report Naser, Naser Abdulla, Habib Kadhem, Husain Egypt J Intern Med Case Report Infection with tuberculosis (TB) still considered a leading infectious cause of death, osteomyelitis TB rare entity, and being extraspinal MDR-TB make it very rare case; most of experience in treating osteomyelitis TB was derived from pulmonary TB experience, and we present a case of humerus MDR-TB that was treated for 5 years, with several interruption due to side effect and other causes. Springer Berlin Heidelberg 2023-06-13 2023 /pmc/articles/PMC10262133/ /pubmed/37333427 http://dx.doi.org/10.1186/s43162-023-00225-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Naser, Naser
Abdulla, Habib
Kadhem, Husain
Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report
title Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report
title_full Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report
title_fullStr Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report
title_full_unstemmed Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report
title_short Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report
title_sort extra-long treatment of mdr-tb osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262133/
https://www.ncbi.nlm.nih.gov/pubmed/37333427
http://dx.doi.org/10.1186/s43162-023-00225-0
work_keys_str_mv AT nasernaser extralongtreatmentofmdrtbosteomyelitisofhumerusduetoneurotoxicityfromthe2ndlinedrugsacasereport
AT abdullahabib extralongtreatmentofmdrtbosteomyelitisofhumerusduetoneurotoxicityfromthe2ndlinedrugsacasereport
AT kadhemhusain extralongtreatmentofmdrtbosteomyelitisofhumerusduetoneurotoxicityfromthe2ndlinedrugsacasereport

Ejemplares similares